nrclinonc

Post on 22-Jan-2016

39 Views

Category:

Documents

3 Downloads

Preview:

Click to see full reader

DESCRIPTION

Table 3 Ipsilateral and contralateral risk after treatment based on studies of BRCA genotype and age at diagnosis. Trainer, A. H. et al. (2010) The role of BRCA mutation testing in determining breast cancer therapy Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.175. - PowerPoint PPT Presentation

TRANSCRIPT

Table 3 Ipsilateral and contralateral risk after treatment based on studies of BRCA genotype and age at diagnosis

Trainer, A. H. et al. (2010) The role of BRCA mutation testing in determining breast cancer therapyNat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.175

top related